Ignite Creation Date:
2024-05-06 @ 3:09 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04531046
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-26
First Post:
2020-08-25
Brief Title:
Axi-Cel as a 2nd Line Therapy in Patients With RelapsedRefractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Sponsor:
Organization:
The Lymphoma Academic Research Organisation